BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38898339)

  • 1. Association between serum insulin-like growth factor 1 and osteoporosis risk in Parkinson's disease: a cross-sectional study.
    Geng C; Chen C
    Neurol Sci; 2024 Jun; ():. PubMed ID: 38898339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and Sarcopenia.
    Tan YJ; Lim SY; Yong VW; Choo XY; Ng YD; Sugumaran K; Md Shah MN; Raja Aman RRA; Paramasivam SS; Mohd Ramli N; Grossmann M; Tan AH
    J Clin Densitom; 2021; 24(3):351-361. PubMed ID: 32888777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis.
    Toussirot E; Nguyen NU; Dumoulin G; Regnard J; Wendling D
    Br J Rheumatol; 1998 Nov; 37(11):1172-6. PubMed ID: 9851264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum uric acid levels with bone mineral density and the presence of osteoporosis in Chinese patients with Parkinson's disease: a cross-sectional study.
    Ma C; Yu R; Li J; Wang X; Guo J; Xiao E; Liu P
    J Bone Miner Metab; 2023 Sep; 41(5):714-726. PubMed ID: 37420115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women.
    Liu JM; Zhao HY; Ning G; Chen Y; Zhang LZ; Sun LH; Zhao YJ; Xu MY; Chen JL
    J Bone Miner Metab; 2008; 26(2):159-64. PubMed ID: 18301972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients.
    Jehle PM; Schulten K; Schulz W; Jehle DR; Stracke S; Manfras B; Boehm BO; Baylink DJ; Mohan S
    Eur J Intern Med; 2003 Feb; 14(1):32-38. PubMed ID: 12554008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum IGF-1 and ET-1 levels in patients with osteoporosis and its clinical significance.
    Sun L; Su J; Wang M
    Pak J Med Sci; 2019; 35(3):691-695. PubMed ID: 31258577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.
    Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):38-43. PubMed ID: 14758570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Bone Mineral Density in Patients with Parkinson's Disease: A Cross-Sectional Study from Chinese Mainland.
    Gao H; Wei X; Liao J; Wang R; Xu J; Liu X; Pan X; Li Z; Li Z; Xia Y; Wang Q
    Front Aging Neurosci; 2015; 7():203. PubMed ID: 26578949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.
    Ghazi Sherbaf F; Mohajer B; Ashraf-Ganjouei A; Mojtahed Zadeh M; Javinani A; Sanjari Moghaddam H; Shirin Shandiz M; Aarabi MH
    Front Endocrinol (Lausanne); 2018; 9():608. PubMed ID: 30450079
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
    Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.